FdaApplication
ANDA 213041
Identifiers
- fda_app_no: ANDA213041
Properties
| Property | Value |
|---|---|
| applicant_name | INVAGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-08-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 10MG BASE/ML | FOR SUSPENSION;ORAL |
1 product